Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Nexium | Where To Buy Next
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
Early detection of thrombin activity in neuroinflammatory disease.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Pain and Cognition in Multiple Sclerosis.
MUNDUS project: MUltimodal Neuroprosthesis for daily Upper limb Support.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Neurology in the developing world.
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy.
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
Disease course heterogeneity and OCT in multiple sclerosis.
Panic disorder as presenting symptoms of multiple sclerosis.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »